Status:
UNKNOWN
Effect of Atorvastatin and Lifestyle Intervention on Progression of Pre-Clinical Atherosclerosis
Lead Sponsor:
Ministry of Science and Technology of the People´s Republic of China
Collaborating Sponsors:
Peking University First Hospital
Conditions:
Atherosclerosis
Eligibility:
All Genders
40-70 years
Phase:
NA
Brief Summary
The purpose of this study is to determine whether atorvastatin, aggressive lifestyle intervention, and their interaction are effective in delaying the progress of pre-clinical atherosclerosis.
Detailed Description
Primary prevention of atherosclerotic disease remains a big challenge. Currently, it is not clear how to treat those subjects with evidence of pre-clinical atherosclerosis but without obvious conventi...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- CIMT is not less than 0.9 mm
- without Clinical diagnosis of atherosclerotic disease
- without Diabetes
Exclusion
Key Trial Info
Start Date :
February 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2010
Estimated Enrollment :
1200 Patients enrolled
Trial Details
Trial ID
NCT00723320
Start Date
February 1 2008
End Date
December 1 2010
Last Update
August 25 2008
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Peking University First Hospital
Beijing, Beijing Municipality, China, 100034